KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Interest Coverage Ratio: 2019-2025

Historic Interest Coverage Ratio for Royalty Pharma (RPRX) over the last 7 years, with Sep 2025 value amounting to 5.37.

  • Royalty Pharma's Interest Coverage Ratio fell 51.43% to 5.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 5.49, marking a year-over-year decrease of 26.41%. This contributed to the annual value of 5.73 for FY2024, which is 28.10% down from last year.
  • Latest data reveals that Royalty Pharma reported Interest Coverage Ratio of 5.37 as of Q3 2025, which was up 75.72% from 3.06 recorded in Q2 2025.
  • Royalty Pharma's 5-year Interest Coverage Ratio high stood at 19.90 for Q2 2021, and its period low was -10.28 during Q4 2022.
  • Over the past 3 years, Royalty Pharma's median Interest Coverage Ratio value was 5.50 (recorded in 2024), while the average stood at 6.25.
  • Per our database at Business Quant, Royalty Pharma's Interest Coverage Ratio tumbled by 414.73% in 2022 and then surged by 590.76% in 2025.
  • Quarterly analysis of 5 years shows Royalty Pharma's Interest Coverage Ratio stood at 3.27 in 2021, then crashed by 414.73% to -10.28 in 2022, then spiked by 226.18% to 12.97 in 2023, then plummeted by 57.61% to 5.50 in 2024, then plummeted by 51.43% to 5.37 in 2025.
  • Its Interest Coverage Ratio was 5.37 in Q3 2025, compared to 3.06 in Q2 2025 and 8.19 in Q1 2025.